Representative before the EPO

Technology company logo thumb
no operation time available
2 offices
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
2 offices
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Mylène Audrey Séverine Quellari has worked on the following 8 EPO patent applications which have been published in the last five years:

EP11729733

HEXAFLUOROISOPROPYL CARBAMATE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION

IPC classification:
A61K 31/4468, A61P 25/00, C07D 205/04, C07D 207/12, C07D 207/14, C07D 211/16, C07D 211/46, C07D 211/54, C07D 211/58, C07D 211/62, C07D 401/12, C07D 403/04, C07D 405/12, C07D 409/12, C07D 413/12
Applicant:
Sanofi, S.A.
Applicant:
Sanofi
Agent:
Johann Then, Sanofi-Aventis Deutschland GmbH
Agent:
Mylène Audrey Séverine Quellari, Sanofi, S.A.
Status:
PATENT GRANTED
EP11749535

ANTICANCER DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF

IPC classification:
A61P 35/00, C07D 487/04
Applicant:
Sanofi, S.A.
Agent:
Mylène Audrey Séverine Quellari, Sanofi, S.A.
Status:
GRANT OF PATENT INTENDED
EP12806060

NOVEL THERAPEUTIC USE OF P75 RECEPTOR ANTAGONISTS

IPC classification:
A61K 31/497, A61K 31/498, A61K 31/506, A61P 13/10
Applicant:
Sanofi, S.A.
Agent:
Mylène Audrey Séverine Quellari, Sanofi, S.A.
Status:
EXAMINATION IN PROGRESS
EP11796752

NOVEL INDOLIZINE DERIVATIVES, AND PREPARATION AND THERAPEUTIC USE THEREOF

IPC classification:
A61K 31/443, A61P 9/00, C07D 471/04
Applicant:
Sanofi, S.A.
Agent:
Mylène Audrey Séverine Quellari, Sanofi, S.A.
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP10801662

NOVEL (HETEROCYCLE/CONDENSED PIPERIDINE)-(PIPERAZINYL)-1-ALCANONE OR (HETEROCYCLE/CONDENSED PYRROLIDINE)-(PIPERAZINYL)-1-ALCANONE DERIVATIVES, AND USE THEREOF AS P75 INHIBITORS

IPC classification:
A61K 31/381, A61K 31/429, C07D 471/04, C07D 495/04, C07D 513/04
Applicant:
Sanofi, S.A.
Applicant:
Sanofi
Agent:
Mylène Audrey Séverine Quellari, Sanofi
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP10801663

NOVEL (HETEROCYCLE/TETRAHYDROPYRIDINE)-(PIPERAZINYL)-1-ALCANONE AND (HETEROCYCLE/DIHYDROPYRROLIDINE)-(PIPERAZINYL)-1-ALCANONE DERIVATIVES, AND USE THEREOF AS P75 INHIBITORS

IPC classification:
A61K 31/496, A61K 31/497, A61K 31/4995, A61K 31/506, A61K 31/551, A61P 25/00, C07D 401/04, C07D 401/14, C07D 403/14, C07D 407/04, C07D 407/14, C07D 409/04, C07D 409/14, C07D 495/04
Applicant:
Sanofi, S.A.
Applicant:
Sanofi
Agent:
Mylène Audrey Séverine Quellari, Sanofi, S.A.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14784452

4-[5-(3-CHLORO-PHENOXY)-OXAZOLO[5,4-D]PYRIMIDIN-2-YL]-2,6-DIMETHYL-PHENOXY}-ACETIC ACID FOR USE IN THE PREVENTION OR TREATMENT OF ACUTE KIDNEY INJURY

IPC classification:
A61K 31/519, A61P 13/12
Applicant:
Sanofi, S.A.
Agent:
Mylène Audrey Séverine Quellari, Sanofi, S.A.
Status:
GRANT OF PATENT INTENDED
EP12178418

Spirocyclic nitriles as inhibitors of protease

IPC classification:
A61K 31/438, A61P 19/00, A61P 35/00, C07C 255/46, C07D 211/66, C07D 213/26, C07D 231/54, C07D 263/52, C07D 295/215, C07D 295/26, C07D 317/72, C07D 471/10, C07D 491/10, C07D 498/10
Applicant:
Sanofi, S.A.
Agent:
Mylène Audrey Séverine Quellari, Sanofi, S.A.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT

Please Sign in to use this feature